These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 35434003)

  • 21. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.
    Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G
    Front Genet; 2022; 13():1085700. PubMed ID: 36579330
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
    Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
    Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Novel Biomarkers for Predicting Prognosis and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma Based on ceRNA Network and Immune Infiltration Analysis.
    Guo Y; Pan WK; Wang ZW; Su WH; Xu K; Jia H; Chen J
    Biomed Res Int; 2021; 2021():4532438. PubMed ID: 34917682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes.
    Peng G; Chi H; Gao X; Zhang J; Song G; Xie X; Su K; Song B; Yang J; Gu T; Li Y; Xu K; Li H; Liu Y; Tian G
    Front Genet; 2022; 13():1010044. PubMed ID: 36406133
    [No Abstract]   [Full Text] [Related]  

  • 26. A Ferroptosis-Related Prognostic Signature Based on Antitumor Immunity and Tumor Protein p53 Mutation Exploration for Guiding Treatment in Patients With Head and Neck Squamous Cell Carcinoma.
    Fan X; Ou Y; Liu H; Zhan L; Zhu X; Cheng M; Li Q; Yin D; Liao L
    Front Genet; 2021; 12():732211. PubMed ID: 34616431
    [No Abstract]   [Full Text] [Related]  

  • 27. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma.
    Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL
    Front Immunol; 2022; 13():969034. PubMed ID: 36466881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a prognostic prediction model based on a combined multi-omics analysis of head and neck squamous cell carcinoma cell pyroptosis-related genes.
    Chen B; Luo Y; Kang X; Sun Y; Jiang C; Yi B; Yan X; Chen Y; Shi R
    Front Genet; 2022; 13():981222. PubMed ID: 36246601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
    Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
    World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
    Baysal H; Siozopoulou V; Zaryouh H; Hermans C; Lau HW; Lambrechts H; Fransen E; De Pauw I; Jacobs J; Peeters M; Pauwels P; Vermorken JB; Smits E; Lardon F; De Waele J; Wouters A
    Front Immunol; 2022; 13():1001161. PubMed ID: 36268020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
    Wang Z; Yuan H; Huang J; Hu D; Qin X; Sun C; Chen G; Wang B
    Head Neck; 2021 Jan; 43(1):182-197. PubMed ID: 33009692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma.
    Gao X; Zhao N; Dong L; Zheng X; Zhang Y; Ding C; Zhao S; Ma Z; Wang Y
    Front Oncol; 2021; 11():735993. PubMed ID: 34900686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High SQLE Expression and Gene Amplification Correlates with Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
    Liu Y; Fang L; Liu W
    Cancer Manag Res; 2021; 13():4709-4723. PubMed ID: 34163246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
    Fang J; Yang Z; Xie J; Li Z; Hu C; Yang M; Zhou X
    Transl Oncol; 2021 Jul; 14(7):101094. PubMed ID: 33878525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients.
    Knebel M; Körner S; Kühn JP; Wemmert S; Brust L; Smola S; Wagner M; Bohle RM; Morris LGT; Pandey A; Schick B; Linxweiler M
    Front Immunol; 2023; 14():1172768. PubMed ID: 37383237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Inflammatory Response-Related Gene Signature Improves High-Risk Survival Prediction in Patients With Head and Neck Squamous Cell Carcinoma.
    Han Y; Ding Z; Chen B; Liu Y; Liu Y
    Front Genet; 2022; 13():767166. PubMed ID: 35480305
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased Immune Infiltration and Improved Prognosis of Head and Neck Squamous Cell Carcinoma Associated with Reduced Ancient Ubiquitous Protein 1 Gene Expression.
    Wang Y; Wu Q; Wei X; Huang G; Feng G; Xu H; Gou X
    Mol Biotechnol; 2024 Jun; ():. PubMed ID: 38862860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
    J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring NK-Cell molecules that impact the immune response and microenvironment in head and neck squamous cell carcinoma.
    Shao P; Hu WW; Shi XL; Shu MY; Li DY; Zhou T; Zhao QT
    J Cell Mol Med; 2024 Jan; 28(2):e18045. PubMed ID: 38011007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.